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Abstract
Prenatal exposure to sodium valproate (VPA) is associated with neurodevelop-
mental impairments. Cortical thickness was measured in 16 children exposed
prenatally to VPA and 16 controls. We found increased left inferior frontal
gyrus (IFG; BA45) and left pericalcarine sulcus (BA18) thickness, an association
between VPA dose and right IFG thickness, and a close relationship between
verbal skills and left IFG thickness. A significant interaction between group and
hemispheric IFG thickness showed absence of the normal asymmetry in the IFG
region of VPA-exposed children. These data provide preliminary insights into
the putative neural basis of difficulties experienced by some VPA-exposed
children.
Introduction
Children whose mothers took antiepileptic drugs (AEDs)
during pregnancy are at increased risk of poor cognitive
and behavioural outcomes. Sodium valproate (VPA)
exposure is associated with impaired intellectual1–3 and
language ability.4 The probable causal pathway for the
longer term effects of fetal AED exposure is the child’s
brain development during exposure.
Brain changes occur in adults taking VPA, including
increased atrophy in dementia5 and reduced parietal lobe
cortical thickness in people with epilepsy.6 One study of
adults with in utero AED exposure found reduced grey
matter volume in lentiform nucleus and hypothalamus,7
but the heterogeneous sample (18 people with 14 different
AED combinations) precludes drug-specific interpretations.
Rodent studies suggest that prenatal exposure impacts
on brain development. VPA affects neuronal progenitor
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proliferation,8 increases the number of GABAergic neu-
rons, enhances neuronal differentiation,9 causes morpho-
logical changes in hippocampal astrocytes10,11 and impairs
synaptic plasticity.12,13 Bittigau et al.14 found widespread
and dose-dependent apoptotic neurodegeneration although
others report global cerebral volume loss associated with
high-dose VPA exposure,15 yet increased cerebral volume
with lower doses. VPA-treated adult rats show significant
reduction in cell differentiation following VPA-exposure16
without volume changes, suggesting that measures such as
cortical thickness may prove useful.
Here, we report imaging findings in children exposed
to VPA prenatally. We predicted that widespread reduc-
tions in cortical thickness would be present in exposed
children compared to age- and sex-matched controls.
Methods and Materials
Participants
Participants were 16 children (seven male, one left-handed)
exposed to VPA in utero, recruited to our prospective
long-term cognitive outcomes study3,4 and 16 age- and sex-
matched controls recruited via hospital and community
advertisements whose mothers did not take AEDs or have
epilepsy. The average age of cases was 7.2 years (SD = 0.6;
range 6–8 years) and in controls was 8.1 (SD = 1.0; range 6–
9 years), representing a small but significant difference in age
(P < 0.05). There were no differences in ethnicity between
groups. One child’s mother took VPA and Levetiracetam,
and all others were VPA monotherapy. The mean VPA dose
across pregnancy was 885 mg (SD = 421). The average IQ
of the VPA group was 96.2 (SD = 11.6) and five children’s
scores fell in the low average or borderline range. There was
no significant difference in IQ between VPA exposed chil-
dren and controls (Control mean = 104.3, SD = 12.4,
P > 0.05). Written consent from a parent/guardian and
verbal assent from the child was obtained in all cases.
Data acquisition
Full neuropsychological assessment details are reported
elsewhere.3,4 The two-subtest short-form of the Wechsler
Abbreviated Scale of Intelligence (WASI) was used to
measure controls’ IQ. Magnetic resonance imaging (MRI)
scans were acquired on the 3T Siemens Magnetom Trio
at Murdoch Childrens Research Institute, Melbourne,
using a 12-channel coil. High-resolution 3D T1-weighted
images were acquired (TR = 1900 msec, TE = 2.15 msec,
flip angle = 9°, FOV = 256 mm, 176 slices, 1 mm isotro-
pic voxels). As part of our routine research practice, T2-
weighted scans are included for clinical reporting by pae-
diatric radiologists.
Image analysis
Data were analysed using Freesurfer, an automated seg-
mentation and cortical reconstruction tool. For imaging
processing details, see http://surfer.nmr.mgh.harvard.edu/
fswiki/FreeSurferMethodsCitation. Voxelwise group com-
parisons were conducted, correcting for multiple compar-
isons (P < 0.05, Monte Carlo method). Only differences
that survived this stringent correction step are presented
here. Analyses were repeated excluding data from one
child whose mother took VPA and Levetiracetam. The
findings were unchanged and the total group results are
reported here. Values of significantly different regions
were then used in subsequent statistical analyses (SPSS
21, IBM Corp, 2011). Freesurfer volumes were used to
examine whole brain group differences.
Results
Increased cortical thickness was found in the left inferior
frontal gyrus (IFG) (Pars Opercularis; x, y, z: 52.5, 23.8,
11.3) and left medial occipital cortex (Pericalcarine; x, y,
z: 12.3, 80.6, 14.1). The differences remained when
age was included as a covariate. Total cortical white and
grey matter did not differ between groups (both P > 0.1).
Asymmetry of cortical thickness in the inferior frontal
lobes was seen in controls but not cases; a significant
interaction between group and hemispheric thickness in
the inferior frontal region, controlling for age, was
detected (F(1, 29) = 12.38, P = 0.001; Fig. 1). Post-hoc
analysis showed greater right than left inferior frontal cor-
tical thickness in controls but no such right-left asymme-
try in VPA cases. VPA dose across pregnancy did not
correlate significantly with left inferior frontal thickness
Figure 1. A significant interaction between hemispheric inferior
frontal gyrus cortical thickness in cases (hashed line, square end) and
controls (solid line, round end).
498 ª 2014 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Prenatal Valproate and Brain Development A. G. Wood et al.
(r = 0.17, P = 0.53), however, there was a significant
relationship with the homologous right hemisphere region
(r = 0.57, P = 0.02, two-tailed; Fig. 2A). A trend towards
poorer verbal abilities (Wechsler Intelligence Scale for
Children – 4th Edition WISC Verbal Comprehension
Index Scores) and greater thickness was observed in VPA
cases (r = 0.42, P = 0.12, two-tailed; Fig. 2B). No
abnormalities were detected on visual inspection of the
data by a paediatric radiologist.
Discussion
Our data demonstrate regional structural cortical brain
changes in humans exposed to VPA in utero. Increases
in cortical thickness were identified in children exposed
prenatally to VPA, which is a potent and effective anti-
epileptic drug, widely considered the treatment of choice
for genetic generalized epilepsies. Our findings provide
the first direct insight into its central neural impact on
the developing human brain.
Differences in left IFG cortical thickness and absence
of the usual hemispheric asymmetry in this region are
compelling given the known association between lan-
guage impairments and prenatal VPA exposure. Atypical
hemispheric language specialization in VPA-exposed chil-
dren was predicted by Meador and colleagues2 on the
basis of the pattern of neuropsychological impairment in
their cohort of children. Several groups, including our
own, report significantly reduced verbal intellectual func-
tion and we also showed that specific language impair-
ments occur in VPA-exposed children.4 Meador’s group
also had a higher than usual rate of left handedness,
which is associated with an increased likelihood of atypi-
cal (i.e. bilateral or right-sided) language representation
in the brain. Taken together, these data led to the con-
clusion that VPA exposure in utero impacts on the nor-
mal functional specialization for language. An alternative
explanation is that the atypical hemispheric specialization
is inherited from the child’s mother. Epilepsy is associ-
ated with a higher than usual rate of atypical language
representation.17,18 Nevertheless, this seems unlikely to
account for Meador and colleagues’ hypothesis and our
findings because atypical language dominance is typically
a feature of lesional epilepsy, and VPA is used most often
for idiopathic generalized epilepsy. Second, although the
mechanism underlying atypical language in epilepsy is
not well characterized, it is assumed to reflect a shift
away from pathological eloquent cortex19,20 rather than a
genetic factor. Our findings support the idea that there
may be altered functional hemispheric specialization in
children exposed to VPA and future studies will examine
this hypothesis directly.
The minor age discrepancy between our groups is not
the basis for differences in cortical thickness. The findings
were not altered when age was covaried was and the pat-
tern of results is opposite to the expected developmental
processes; greater cortical development in the controls
would in fact minimize the cortical differences found
here. Although there is an overall reduction in grey mat-
ter volume and cortical thickness during childhood and
adolescence,21,22 thickness in specific regions such as left
IFG increases with age.21 Thus, controls would show
greater cortical thickness in controls. We found the oppo-
site, suggesting that either the VPA-exposed cases have
enhanced postnatal cortical development relative to their
peers or that the increased thickness represents perturbed
prenatal neurodevelopmental processes.
The association between poorer verbal abilities and
increased cortical thickness in the left IFG suggests that
our results cannot be accounted for by “enhanced” corti-
cal development in the children exposed to VPA. Positive
correlations between IQ and cortical thickness are
reported in adults23; this relationship is not evident in
Figure 2. (A) Valproate (VPA) dose in pregnancy correlates
significantly with right inferior frontal gyrus thickness (B) Left inferior
frontal gyrus thickness is associated with poorer verbal abilities.
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young children (i.e. similar to our cohort) but emerges
later.24 Indeed, the rate of change in cortical thickness is
the salient factor in the relationship with intellectual
skills, with higher levels of ability associated with a later
onset of thinning.24 Thus, existing data that link the mag-
nitude and developmental trajectory of cortical thickness
to intellectual abilities are inconsistent with our findings.
Instead, our findings suggest that there may be a direct
relationship between the structural changes in this region
and cognitive deficits.
The alteration of cortical development in our cohort
is consistent with perturbed prenatal brain development.
The specific basis for this is difficult to discern on the
basis of our findings and the various mechanisms of
action of VPA. For example, VPA increases the availabil-
ity of GABA, which plays a critical role in cortical devel-
opment.25,26 Increased bioavailability in the fetus could
affect the normal execution of GABA-related processes
such as neurite branching and dendrite outgrowth. The
trophic function of GABA is well recognized,25 and
regionally-increased cortical thickness is seen in fetal
alcohol disorder,27 in which GABA is implicated.
Alternative mechanisms may also be relevant to under-
standing the effects of VPA exposure during brain devel-
opment. For example, VPA impacts on the activity of
histone deacetylase and these changes have been shown
to influence social behavior in animal models28 and neu-
ral plasticity.29
Patterns of morphological changes may vary in relation
to the timing of AED exposure,7 and dose may also play a
role. VPA-exposed rodents show abnormalities of cortical
development including increased apoptosis,8,14 however, vol-
ume changes depend on dose, with volume loss at high
dose, yet increased volume at medium doses.15 Our cohort
was exposed to a relatively low average VPA dose; future
studies should include a range of doses to better understand
this effect in humans. In conclusion, this study demonstrates
regional structural brain changes in children exposed to
VPA in utero, and highlights a need for additional research.
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